Concepedia

Kerry D. Fisher

KD

Statistics

Publications

30

Citations

1.5K

H-Index

24

Active since

1999

Affiliations

University of Oxford(Current)

PsiOxus Therapeutics (United Kingdom)

University of Birmingham

Czech Academy of Sciences, Institute of Macromolecular Chemistry

Hybrid Instruments (United Kingdom)

Kerry D. Fisher is an author at University of Oxford specializing in adenovirus vectors, oncology, and adenovirus biology.

Publications per year

1999–2020

30

Publications

30

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Rocio García‐Carbonero, Ramón Salazar, Ignacio Durán et al. · Journal for ImmunoTherapy of Cancer · 2017 · 159 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +13

Adenovirus Type 5 Interactions with Human Blood Cells May Compromise Systemic Delivery

Mark Lyons, David Onion, Nicky K. Green et al. · Molecular Therapy · 2006 · 156 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

Joshua D. Freedman, Joachim Hagel, Eleanor M. Scott et al. · EMBO Molecular Medicine · 2017 · 119 citations · Full text

Life Sciences, Immunology, Oncology +17

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes

Susan Graham, Robert Carlisle, James J. Choi et al. · Journal of Controlled Release · 2013 · 85 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Virotherapy of Ovarian Cancer With Polymer-cloaked Adenovirus Retargeted to the Epidermal Growth Factor Receptor

Jo Morrison, Simon S. Briggs, Nicola Green et al. · Molecular Therapy · 2007 · 83 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

1–5 of 30